Insider Selling: CeriBell, Inc. (NASDAQ:CBLL) CEO Sells 25,000 Shares of Stock

CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) CEO Xingjuan Chao sold 25,000 shares of the company's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $17.70, for a total transaction of $442,500.00. Following the transaction, the chief executive officer owned 776,022 shares in the company, valued at $13,735,589.40. The trade was a 3.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Xingjuan Chao also recently made the following trade(s):

• On Tuesday, June 3rd, Xingjuan Chao sold 25,000 shares of CeriBell stock. The shares were sold at an average price of $17.00, for a total transaction of $425,000.00.
• On Thursday, May 15th, Xingjuan Chao sold 25,000 shares of CeriBell stock. The shares were sold at an average price of $16.96, for a total transaction of $424,000.00.
• On Wednesday, April 23rd, Xingjuan Chao sold 15,628 shares of CeriBell stock. The stock was sold at an average price of $15.11, for a total transaction of $236,139.08.
• On Thursday, April 17th, Xingjuan Chao sold 5,700 shares of CeriBell stock. The stock was sold at an average price of $15.02, for a total transaction of $85,614.00.
• On Monday, April 21st, Xingjuan Chao sold 3,372 shares of CeriBell stock. The shares were sold at an average price of $15.03, for a total transaction of $50,681.16.

CeriBell Stock Up 1.7%

CBLL stock traded up $0.28 during midday trading on Thursday, hitting $16.78. The company's stock had a trading volume of 15,328 shares, compared to its average volume of 285,833. The company has a debt-to-equity ratio of 0.11, a quick ratio of 16.81 and a current ratio of 17.36. CeriBell, Inc. has a 52-week low of $10.01 and a 52-week high of $32.75. The firm has a 50-day simple moving average of $17.52 and a 200-day simple moving average of $19.84.

CeriBell (NASDAQ:CBLL - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported ($0.36) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.07. The firm had revenue of $20.49 million for the quarter, compared to analysts' expectations of $19.30 million. As a group, equities analysts predict that CeriBell, Inc. will post -2.46 EPS for the current year.

Institutional Investors Weigh In On CeriBell

Institutional investors and hedge funds have recently bought and sold shares of the stock. Ameriprise Financial Inc. purchased a new stake in CeriBell in the fourth quarter valued at $368,000. Corebridge Financial Inc. purchased a new stake in CeriBell during the fourth quarter worth about $158,000. PNC Financial Services Group Inc. purchased a new stake in CeriBell during the fourth quarter worth about $47,000. Bank of America Corp DE purchased a new stake in CeriBell during the fourth quarter worth about $498,000. Finally, Massachusetts Financial Services Co. MA purchased a new stake in shares of CeriBell in the fourth quarter valued at about $10,750,000.

Analyst Ratings Changes

A number of research firms have weighed in on CBLL. LADENBURG THALM/SH SH began coverage on shares of CeriBell in a report on Friday, April 4th. They issued a "buy" rating and a $32.00 price objective for the company. BTIG Research started coverage on shares of CeriBell in a research note on Tuesday, June 24th. They issued a "buy" rating and a $30.00 target price on the stock. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $32.14.

CeriBell Company Profile

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.